ชื่อ-สกุล: ศาสตราจารย์ ดร.มัลลิกา อิ่มวงศ์
Name: Professor Mallika Imwong
ตำแหน่ง: หัวหน้าภาควิชา
Position: Head
สังกัด : ภาควิชาชีวโมเลกุลและพันธุศาสตร์โรคเขตร้อน
Department: Molecular Tropical Medicine and Genetics
Tel: 02 306 9100 ต่อ 3078, 1440-1443
Molecular Characterisation of Drug Resistance in the Human Malarias
CGenotyping of Plasmodium vivax
Pharmacogenetic basis of Oseltamivir
G6PD genotyping
Member of scientific committee for ‘Methods and Techniques for Clinical Trials on Antimalarial Drug Efficacy: Genotyping to Identify Parasite Populations’ sponsored by Medicines for Malaria Venture and cosponsored by World Health.
Head of Molecular Regional Reference Laboratory for Asia, organized and supported by WorldWide Antimalarial Resistance Network (WWARN)’ since 2008.
Invited reviewer of manuscripts for international journals including Trends in Parasitology, The Journal of Infectious Diseases, and Malaria Journal.
Principle investigator: Wellcome Trust Career Development Research Fellowship in Public Health and Tropical Medicine, Wellcome Trust of Great Britain Title: ‘Molecular Characterisation of Drug Resistance in the Human Malarias’ during
Principle investigator: National Science and Technology Development Agency, Bangkok, Thailand, Title: VNTR typing of Plasmodium falciparum and Plasmodium vivax.
Principle investigator: The Thailand Research Fund, Bangkok, Thailand, Title: Development of molecular techniques for evaluation of mefloquine resistance in P. falciparum in Asia.
Principle investigator: Wellcome Trust Training Fellow for Research into Infectious Diseases, Wellcome Trust of Great Britain Title: Genotyping of Plasmodium vivax; development of field methods and investigation of the molecular basis of sulfonamide resistance.
Co-investigator: Wellcome Trust of Great Britain, Title: Population biology and epidemiology of two newly recognized human malaria parasite species
Co-investigator: United States Agency for International Development (USAID), Title:Molecular Surveillance of Drug Resistant Malaria in the Greater Mekong Subregion.
Co-investigator: NIH, Title: Characterisation of the Human Carboxylesterase 1 (CES1) mutation(s) which may be responsible for markedly reduced conversion of oseltamivir phosphate to oseltamivir carboxylate
Co-investigator: The Thailand Research Fund, Bangkok, Thailand, Title: Studies on virulent and drug resistant genes of malarial parasites from infected patients for development of molecular test kits